CHELSEY KIGHT: Open Payments
NPI 1669905741 · NORTH CHARLESTON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$423 in 24 payments from 9 companies in 2025. Trend: 2023 $926 · 2024 $525 · 2025 $423
Food & beverage: $423
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $101 |
| SCPHARMACEUTICALS INC. | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| CVRx, Inc. | 3 | $48 |
| Abbott Laboratories | 2 | $44 |
| Alnylam Pharmaceuticals Inc. | 2 | $39 |
| BridgeBio Pharma, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $12 |
Products named: JARDIANCE, FUROSCIX, Barostim Neo System, CARDIOMEMS, ELIQUIS, ONPATTRO, CAMZYOS, AMVUTTRA.
Industry payments across SC — which companies pay providers there.
